The psychobiotic supplements market is projected to expand at a steady pace in the upcoming decade, owing to the increasing number of consumers perceiving benefits of psychobiotics in managing mental health well-being.
Psychobiotic supplements are gaining popularity among health-conscious consumers, especially those affected by stress, anxiety and cognitive decline, as a field of probiotics and prebiotics that seem to modulate neurological health. Increasing evidence surrounding gut microbiota and its influence on mental health is driving the demand for these supplements. Furthermore, increasing plant-based and natural formulations along with biotechnological advances are aiding the market growth.
In 2025, the psychobiotic supplements market was valued at approximately USD 150.87 million. By 2035, it is projected to reach USD 212.82 million, reflecting a compound annual growth rate (CAGR) of 3.5%. Factors such as an aging population, increasing prevalence of mental health disorders, and heightened interest in alternative and preventive healthcare solutions are fueling market growth.
| Metric | Value |
|---|---|
| Market Size in 2025 | USD 150.87 Million |
| Projected Market Size in 2035 | USD 212.82 Million |
| CAGR (2025 to 2035) | 3.5% |
Furthermore, the growing influence of personalized nutrition and tailored supplement formulations is driving the development of innovative psychobiotic products. Key industry players are actively investing in research and development to enhance the efficacy and stability of psychobiotic supplements for various consumer needs.
Explore FMI!
Book a free demo
Due to strong interest in mental health supplements, increased prevalence of anxiety and depression, and growing research on gut-brain interactions, North America continues to be a leading area in the psychobiotic supplements which is also projected to continue the growth through 2032. The USA and Canada are major players, increasing interest in functional foods, dietary supplements and natural health alternatives.
Moreover, a focus on innovation, supportive regulatory environment for probiotics, and well-established retail distribution networks further continue to drive the growth of probiotic products market in the region. Increase in demand for online purchasing and subscription-based supplement model among consumers is growing sales in North America.
Europe psychobiotic supplements market is attributed with high consumer’s consciousness, saturated regulations on probiotic formulations and rising adoption for natural and organic dietary supplements. Germany, the UK, France, and Italy have experienced growing demand for psychobiotics due to the rising cases of stress-based disorders and lifestyle-based health problems.
Furthermore, continuous scientific research surrounding gut-brain connection and mental health is driving product development and consumer preference. With evolving consumer expectations, European manufacturers are working with sustainability and clean-label products.
With the growth of the nutraceutical industries across Asia-Pacific countries such as China, Japan, South Korea, and India and the rising disposable income along with adoption of modernized lifestyles, the region is emerging as a potential market for psychobiotic supplements.
Also, growing awareness regarding traditional systems of medicine and increasing adoption of western lifestyle are escalating the demand for mental health supplements. The growth of the market in this region is driven by factors such as improvements in probiotic technology and government support for gut health studies. Additionally, the growth of e-commerce platforms is allowing for even greater access to products.
Driven by the burgeoning consumer awareness around holistic health, scientific studies, and wide availability of psychobiotic supplements via different online retail channels, the market is poised for consistent growth in the forthcoming decade. Companies are making new formulations with improvements in product stability and development of targeted solutions for specific mental health conditions, thereby driving further market trends and growth in the industry.
Challenge
Regulatory Hurdles and Standardization Issues
However, the Psychobiotic supplements market will face some challenges in terms of regulatory approvals and psychobiotic strains standardization. Companies are faced with complex compliance requirements with varying global regulations governing probiotic and psychobiotic supplements.
The disparity in labelling laws, safety assessments, and health claims in different regions further complicates market penetration. How should companies approach this? By investing in the scientific research needed to substantiate product claims while working closely with regulatory bodies to develop clear guidance on acceptable product claims, and incorporating transparent marketing practices to ensure compliance.
Limited Consumer Awareness and Market Education
Interest in gut-brain health is increasing, but consumer awareness of psychobiotic supplements remains low. This has resulted in slower market adoption because many consumers are still not familiar with the benefits of psychobiotics for mental health and cognition.
False information and skepticism regarding probiotics only hamper growth. To combat this, brands should concentrate on educational marketing, clinical validation of product efficacy and collaborating with healthcare professionals.
Opportunity
Rising Demand for Mental Health and Wellness Solutions
As the gut-brain axis gains traction, interest in psychobiotic supplements is climbing. The search for natural and functional solutions for stress, anxiety and cognitive enhancement continues to drive the market. An emerging trend towards holistic well-being also opens a door for brands to specifically formulate products, introducing psychobiotics paired with adaptogens and nootropics that meet diverse mental health needs.
Expansion of Online Retail and Personalized Nutrition
Emergence of e-commerce and direct-to-consumer sales channels is revolutionizing psychobiotic supplement distribution. Online platforms enable brands to target a broader audience, provide subscription-based options, and employ data analytics for personalized supplement prescriptions.
AI-Powered Psychobiotic companies focusing on personalized microbiome analysis and psychobiotic recommendations based on AI-driven insights and digital marketing strategies will thrive in the expanding psychobiotic supplements sector.
The psychobiotic supplements market experienced steady growth from 2020 to 2024 due to the compound's surging international demand, which was driven by rising interest in gut health among consumers worldwide as well as an increased prevalence of scientific studies and the popularity of probiotic based solutions for improving mental well-being.
Market dynamics were affected by challenges like lack of regulatory standardization and consumer skepticism. Microbiome, AI-driven personalized nutrition, and psychobiotic-enriched functional foods will dominate the future landscape 2025 to 2035.
Market Creation: Brands will continue to build out the market through investment in clinical trials, precision nutrition, and innovation in delivery formats (e.g., gummies, functional beverages) Using blockchain technology to deliver supply chain transparency and better sustainable packaging solutions will boost consumer trust and eco-friendly branding even further.
Market Shifts: A Comparative Analysis 2020 to 2024 vs. 2025 to 2035
| Market Shift | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Inconsistent global regulations for psychobiotic supplements |
| Technological Advancements | Growth in microbiome research and gut-brain axis studies |
| Industry Adoption | Increased interest in probiotic-based mental health products |
| Supply Chain and Sourcing | Dependence on traditional supplement manufacturing |
| Market Competition | Entry of new wellness brands and biotech startups |
| Market Growth Drivers | Consumer shift towards holistic well-being |
| Sustainability and Energy Efficiency | Initial focus on eco-friendly packaging |
| Integration of Smart Monitoring | Limited consumer tracking of gut-brain health |
| Advancements in Product Innovation | Development of psychobiotic capsules and powders |
| Market Shift | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Standardized global frameworks and AI-driven compliance |
| Technological Advancements | AI-based personalized psychobiotic formulations |
| Industry Adoption | Widespread acceptance of psychobiotic-enhanced functional foods |
| Supply Chain and Sourcing | Blockchain-enabled transparency and sustainable ingredient sourcing |
| Market Competition | Dominance of AI-powered supplement companies and pharma collaborations |
| Market Growth Drivers | Personalized microbiome-based nutrition and targeted formulations |
| Sustainability and Energy Efficiency | Large-scale adoption of biodegradable materials and carbon-neutral production |
| Integration of Smart Monitoring | IoT-enabled microbiome analysis and AI-based dietary recommendations |
| Advancements in Product Innovation | Expansion into psychobiotic beverages, functional snacks, and personalized supplements |
Psychobiotic supplements in North America held a significant share of the market owing to high consumer awareness, particularly in the USA with respect to gut-brain health and mental wellness. Growing interest in the prevention of stress, anxiety and digestive health against the backdrop of a pandemic is increasing demand for probiotics and microbiome-based solutions.
Market growth can be attributed to the accessibility of psychobiotic supplements in the form of capsules, powders, functional foods, and others. Moreover, investments by supplement manufacturers in research and development, as well as partnerships with healthcare professionals also contribute to market expansion.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 3.7% |
Psychobiotics supplements market in the UK is growing at a moderate pace due to increasing preference for natural solutions for mental health issues. Growing demand for probiotics in functional foods and dietary supplements is supporting market growth. Psychobiotic products are becoming more available to the general public, thanks to retail channels such as e-commerce and health-oriented stores.
And an increasing amount of scientific evidence connecting gut health to cognitive function is driving purchasing decisions as well. This is further propelling the market growth owing to the presence of various innovative start-ups and product launches to target mental well-being.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 3.4% |
The psychobiotic supplements market is burgeoning in the European Union, primarily led by Germany, France, and Italy. Demand is being driven by rising consumer awareness of the gut-brain axis, and the healthy gut-brain axis is said to be beneficial in the treatment of stress and mood disorders.
The rigorous regulation of probiotic supplements also minimizes the chances for low-grade products to show up on the market. The increasing use of plant-based and vegan probiotics is further supporting the diversification of product offerings. Market expansion and innovation are being supported through partnerships between research institutions and dietary supplement firms.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union (EU) | 3.6% |
Psychobiotic supplements market in Japan is dynamic and driven by a high demand for functional foods and probiotics that support mental well-being. The focus on longevity and preventive healthcare within the country encourages consumers towards psychobiotic supplementation in their everyday wellness regimen.
This growth is attributed to the presence of established probiotic brands and developments of psychobiotic-fortified fermented foods. In addition to this, rising research on gut microbiota and its influence on psychological wellbeing is also resulting in product innovations and bolstering consumer uptake in the region.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 3.8% |
Psycho-prebiotics market is prospering in South Korea with a health-promoting populace and a high consuming demand for functional foods. This emerging trend also extends to psychobiotics in beauty and wellness products. A flourishing nutraceutical industry, led by solid government schemes and funds to probiotic institutes, propels the market growth of the country.
Meanwhile, increased focus on precision nutrition and personalized supplements are also drawing consumers interested in customized mental health solutions. E-commerce and direct-to-consumer channels are also proving vital in terms of accessibility and market penetration.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 3.9% |
| Form | Market Share (2025) |
|---|---|
| Capsules | 62% |
Keeping the consumer in priority, capsules account for the largest share in psychobiotic supplements market owing to their ease of consumption, specific dosage and prevention of spoilage. Powder and liquid forms have disadvantages, as capsules protect live strain from evaporation, until you reach the gut.
Psycho-biotic supplements for mood and cognition are often offered in capsule form due to the increasing demand for targeted health benefits. Plus, new delayed-release capsules help them do their job better. In recent years, the increasing trend towards plant-based and vegetarian-friendly capsules has added to the allure of these capsules among consumers desiring organic and earth-friendly supplement solutions.
With the increasing understanding of gut-brain axis interactions, manufacturers are introducing innovative formulations for capsule supplements enhancing bioavailability and mental well-being benefits. Pharmaceutical companies have invested heavily in high-tech encapsulation techniques like microencapsulation or enteric coating, to make psychobiotic supplements more stable and effective at delivering health benefits.
| Distribution Channel | Market Share (2025) |
|---|---|
| Store-Based Retail | 58% |
Thus, the psychobiotic supplements market is highly dominated by store-based retail, such as specialty stores, supermarkets, and hypermarkets, as consumers prefer to select specific products themselves and are inclined to take advice from experts available at these stores. Consumers rely on brick-and-mortar stores to offer authentic and high-quality products; they are the primary sales channel.
Educating customers on the benefits of psychobiotic supplements through specialty stores results in higher sales conversion rates. Consumer confidence in retail purchases are further boosted by the availability of different brands, offers and the ability to authenticate products.
Moreover, sales growth is being driven by the growing collaboration between supplement manufacturers and retailers to design exclusive in-store experiences and discounts. With the increasing footprint of health and wellness sections in supermarkets and hypermarkets, the dominance of store-based retail will continue to grow through the next years. Virtual retailers in the space are developing recommendations based on machine learning models, further securing their position as the destination.
Psychobiotic supplements market is driven by increase in gut-brain connection awareness, rising number of mental health benefits and probiotic based cognitive support. There is a growing demand for psychobiotics as consumers increasingly turn to natural solutions for stress, anxiety, and mood enhancement.
To differentiate themselves, companies are concentrating on scientifically sound formulations, novel delivery forms and stratified probiotic-prebiotic formulations. The growth of e-commerce channels, personalized nutrition trends, and regulatory approvals regarding gut-mind health claims will continue to drive market expansion.
With a worldwide Compound Annual Growth Rate (CAGR) of 3.5%, important participants are capitalizing on scientific research, useful food applications, and pure-label formulations to drive their online product portfolios. The market is further aided by growing investments in the microbiome space and AI-led personalized supplementation offerings.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| OptiBiotix Health Plc | 22-26% |
| Kerry Group Plc | 16-20% |
| Seed Health | 12-16% |
| Probi AB | 10-14% |
| UAS Labs | 8-12% |
| Other Companies (combined) | 25-35% |
| Company Name | Key Offerings/Activities |
|---|---|
| OptiBiotix Health Plc | In 2025, OptiBiotix Health Plc introduced psychobiotic formulations targeting stress and sleep enhancement, integrating microbiome modulation with precision nutrition for enhanced mental well-being. |
| Kerry Group Plc | In 2024, Kerry Group Plc expanded its probiotic ingredient portfolio with clinically validated strains, supporting cognitive function, mood regulation, and gut-brain axis health. |
| Seed Health | In 2025, Seed Health launched next-generation psychobiotics focused on neuroinflammation reduction and serotonin modulation, backed by rigorous clinical trials for improved efficacy. |
| Probi AB | In 2024, Probi AB strengthened its research partnerships to develop psychobiotics targeting anxiety and mood stabilization, leveraging proprietary bacterial strains with proven neuroprotective effects. |
| UAS Labs | In 2025, UAS Labs unveiled capsule-based psychobiotic supplements for personalized gut-brain support, ensuring higher probiotic survival rates and enhanced bioavailability. |
Key Company Insights
OptiBiotix Health Plc (22-26%)
OptiBiotix Health Plc is at the forefront of psychobiotic market with science backed formulations focusing on the gut-microbiome modulation for enhancing mental well-being. The liner stands out for its emphasis on precision nutrition, high-potency probiotic strains and symbiotic solutions. Its substantial investment in personalized wellness and therapies aimed at the microbiome solidifies its position in this area.
Kerry Group Plc (16-20%)
Functional probiotics are one of the stars of the show here, with Kerry Group Plc being one of the pioneers, with a variety of clinically validated psychobiotic strains that promote stress resilience, mood and cognitive function. It combines cutting-edge science with scalable production technologies - and is able to deliver its products worldwide while guaranteeing quality.
Seed Health (12-16%)
As a leader in microbiome research and psychobiotic innovation, Seed Health develops multi-strain formulations that optimize gut-brain interactions. The brand is known for its very bioavailable, clinically tested and precision-targeted psychobiotics.
Probi AB (10-14%)
That's why Probi AB has become a leader in psychobiotic-driven mental wellness solutions, working with top research institutes to validate their neuroactive probiotic strains. In order to solidify its market position, the company is expanding its clinical evidence, regulatory approvals, and consumer-friendly formulations.
UAS Labs (8-12%)
UAS Labs focuses on the development of stable, encapsulated psychobiotics with guaranteed viability and therapeutic potency. It specializes in next-gen probiotic technologies, immune-boosting psychobiotic blends and data-driven product development.
Other Key Players (25-35% Combined)
With more upcoming Psychobiotic supplements like these, there are a few different companies adding to the gut-brain axis treatment space:
The overall market size for psychobiotic supplements market was USD 150.87 million in 2025.
The psychobiotic supplements market expected to reach USD 212.82 million in 2035.
Rising awareness of gut-brain health, increasing prevalence of stress-related disorders, growing consumer preference for natural supplements, and expanding research on microbiome benefits will drive psychobiotic supplements market demand.
The top 5 countries which drives the development of psychobiotic supplements market are USA, UK, Europe Union, Japan and South Korea.
Capsules segment driving market growth to command significant share over the assessment period.
Aquafeed Enzymes Market Analysis by Enzyme Type, Form, Aquatic Animal, and Region Through 2035
Coconut Butter Market Analysis by End-use Application Sales Channel Through 2025 to 2035
Hydrotreated Vegetable Oil Market Analysis by Type and Application Through 2035
Animal Feed Preservative Market Outlook by Product Type, End-Use Application, Form and Others Through 2035
Artificial Preservative Market Outlook by Product, Type, Form, End Use Application and Others Through 2035
Aqua Feed Additives Market Analysis by Species Type, Ingredient and Other Additives Types Through 2035
Psychobiotic Supplements Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
